Hands-on guide to clinical pharmacology [[electronic resource] /] / Christopher Tofield, Alexander Milson, Sukhdev Chatu |
Autore | Tofield Christopher |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Malden, Mass., : Blackwell Pub., 2005 |
Descrizione fisica | viii, 200 p |
Disciplina | 615/.1 |
Altri autori (Persone) |
ChatuSukhdev
MilsonAlexander |
Soggetto topico |
Clinical pharmacology
Pharmacology |
ISBN |
0-470-75025-1
0-470-75074-X 1-281-32204-0 9786611322045 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910809269403321 |
Tofield Christopher
![]() |
||
Malden, Mass., : Blackwell Pub., 2005 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The hands-on guide to practical prescribing [[electronic resource] /] / Oliver Jones, Nandan Gautam |
Autore | Jones Oliver (Oliver M.) |
Pubbl/distr/stampa | Malden, Mass., : Blackwell, 2004 |
Descrizione fisica | 1 online resource (202 p.) |
Disciplina | 615/.14 |
Altri autori (Persone) | GautamNandan |
Soggetto topico |
Drugs - Prescribing
Clinical pharmacology |
ISBN |
1-281-30885-4
9786611308858 0-470-79599-9 0-470-75069-3 1-4051-4067-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
The hands-on guide to practical prescribing; Contents; Abbreviations; 1 General introduction; 2 Practical aspects of how to prescribe; 3 How to use the British National Formulary (BNF) and Monthly Index of Medical Specialties (MIMS); 4 Drug interactions; 5 Monitoring of drugs, overdose and toxicity; 6 Adverse drug reactions and allergies; 7 Prescribing in children; 8 Prescribing in the elderly; 9 Conception, pregnancy and breast-feeding; 10 Surgical patients: the preoperative stage; 11 Intravenous fluids; 12 Nutrition; 13 Analgesia: management of acute pain; 14 The acute surgical abdomen
15 Vascular surgical issues: ischaemia (acute, chronic and prevention)16 Breast problems; 17 Urological problems: benign prostatic hypertrophy, incontinence and infections; 18 Deep vein thrombosis prophylaxis and the surgical patient; 19 Antibiotic prophylaxis; 20 Bowel preparation; 21 Wounds and abscesses, including dressings; 22 Anticoagulation; 23 Transfusion of blood products; 24 The patient on steroids, the oral contraceptive pill or hormone replacement therapy; 25 Prescribing in organ failure; 26 Drugs acting on the cardiovascular system; 27 Hypertension; 28 Cardiac arrhythmias 29 Airways disease30 Oxygen therapy; 31 Musculoskeletal drugs; 32 Movement disorders and epilepsy; 33 Altered conscious level and stroke; 34 Constipation, diarrhoea and bowel disease; 35 Nausea and vomiting; 36 Gastro-oesophageal reflux and peptic ulcer disease; 37 Insomnia, nocturnal confusion and the aggressive patient; 38 Drug dependency syndromes; 39 Palliative care and the management of chronic pain; 40 Diabetes; Appendix: Sample prescription form; Index |
Record Nr. | UNINA-9910145695303321 |
Jones Oliver (Oliver M.)
![]() |
||
Malden, Mass., : Blackwell, 2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The hands-on guide to practical prescribing [[electronic resource] /] / Oliver Jones, Nandan Gautam |
Autore | Jones Oliver (Oliver M.) |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Malden, Mass., : Blackwell, 2004 |
Descrizione fisica | 1 online resource (202 p.) |
Disciplina | 615/.14 |
Altri autori (Persone) | GautamNandan |
Soggetto topico |
Drugs - Prescribing
Clinical pharmacology |
ISBN |
1-281-30885-4
9786611308858 0-470-79599-9 0-470-75069-3 1-4051-4067-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
The hands-on guide to practical prescribing; Contents; Abbreviations; 1 General introduction; 2 Practical aspects of how to prescribe; 3 How to use the British National Formulary (BNF) and Monthly Index of Medical Specialties (MIMS); 4 Drug interactions; 5 Monitoring of drugs, overdose and toxicity; 6 Adverse drug reactions and allergies; 7 Prescribing in children; 8 Prescribing in the elderly; 9 Conception, pregnancy and breast-feeding; 10 Surgical patients: the preoperative stage; 11 Intravenous fluids; 12 Nutrition; 13 Analgesia: management of acute pain; 14 The acute surgical abdomen
15 Vascular surgical issues: ischaemia (acute, chronic and prevention)16 Breast problems; 17 Urological problems: benign prostatic hypertrophy, incontinence and infections; 18 Deep vein thrombosis prophylaxis and the surgical patient; 19 Antibiotic prophylaxis; 20 Bowel preparation; 21 Wounds and abscesses, including dressings; 22 Anticoagulation; 23 Transfusion of blood products; 24 The patient on steroids, the oral contraceptive pill or hormone replacement therapy; 25 Prescribing in organ failure; 26 Drugs acting on the cardiovascular system; 27 Hypertension; 28 Cardiac arrhythmias 29 Airways disease30 Oxygen therapy; 31 Musculoskeletal drugs; 32 Movement disorders and epilepsy; 33 Altered conscious level and stroke; 34 Constipation, diarrhoea and bowel disease; 35 Nausea and vomiting; 36 Gastro-oesophageal reflux and peptic ulcer disease; 37 Insomnia, nocturnal confusion and the aggressive patient; 38 Drug dependency syndromes; 39 Palliative care and the management of chronic pain; 40 Diabetes; Appendix: Sample prescription form; Index |
Record Nr. | UNISA-996208273903316 |
Jones Oliver (Oliver M.)
![]() |
||
Malden, Mass., : Blackwell, 2004 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
The hands-on guide to practical prescribing [[electronic resource] /] / Oliver Jones, Nandan Gautam |
Autore | Jones Oliver (Oliver M.) |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Malden, Mass., : Blackwell, 2004 |
Descrizione fisica | 1 online resource (202 p.) |
Disciplina | 615/.14 |
Altri autori (Persone) | GautamNandan |
Soggetto topico |
Drugs - Prescribing
Clinical pharmacology |
ISBN |
1-281-30885-4
9786611308858 0-470-79599-9 0-470-75069-3 1-4051-4067-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
The hands-on guide to practical prescribing; Contents; Abbreviations; 1 General introduction; 2 Practical aspects of how to prescribe; 3 How to use the British National Formulary (BNF) and Monthly Index of Medical Specialties (MIMS); 4 Drug interactions; 5 Monitoring of drugs, overdose and toxicity; 6 Adverse drug reactions and allergies; 7 Prescribing in children; 8 Prescribing in the elderly; 9 Conception, pregnancy and breast-feeding; 10 Surgical patients: the preoperative stage; 11 Intravenous fluids; 12 Nutrition; 13 Analgesia: management of acute pain; 14 The acute surgical abdomen
15 Vascular surgical issues: ischaemia (acute, chronic and prevention)16 Breast problems; 17 Urological problems: benign prostatic hypertrophy, incontinence and infections; 18 Deep vein thrombosis prophylaxis and the surgical patient; 19 Antibiotic prophylaxis; 20 Bowel preparation; 21 Wounds and abscesses, including dressings; 22 Anticoagulation; 23 Transfusion of blood products; 24 The patient on steroids, the oral contraceptive pill or hormone replacement therapy; 25 Prescribing in organ failure; 26 Drugs acting on the cardiovascular system; 27 Hypertension; 28 Cardiac arrhythmias 29 Airways disease30 Oxygen therapy; 31 Musculoskeletal drugs; 32 Movement disorders and epilepsy; 33 Altered conscious level and stroke; 34 Constipation, diarrhoea and bowel disease; 35 Nausea and vomiting; 36 Gastro-oesophageal reflux and peptic ulcer disease; 37 Insomnia, nocturnal confusion and the aggressive patient; 38 Drug dependency syndromes; 39 Palliative care and the management of chronic pain; 40 Diabetes; Appendix: Sample prescription form; Index |
Record Nr. | UNINA-9910812303103321 |
Jones Oliver (Oliver M.)
![]() |
||
Malden, Mass., : Blackwell, 2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Histaminergic neurotransmission as a gateway for the effects of the fat sensing molecule Oleoylethanolamide : Focus on cognition and stress-reactivity / / Alessia Costa |
Autore | Costa Alessia |
Pubbl/distr/stampa | Florence : , : Firenze University Press, , 2019 |
Descrizione fisica | 1 online resource (124 pages) |
Disciplina | 615.1 |
Collana | Premio Tesi di Dottorato |
Soggetto topico | Clinical pharmacology |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Histaminergic neurotransmission as a gateway for the effects of the fat sensing molecule Oleoylethanolamide |
Record Nr. | UNINA-9910572182903321 |
Costa Alessia
![]() |
||
Florence : , : Firenze University Press, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
IBJ clinical pharmacology |
Pubbl/distr/stampa | Madrid : , : Ibero-American Journals (IBJ) |
Descrizione fisica | 1 online resource |
Soggetto topico | Clinical pharmacology |
Soggetto genere / forma | Periodicals. |
ISSN | 2530-4984 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | spa |
Altri titoli varianti | IBJ-CP |
Record Nr. | UNISA-996320979403316 |
Madrid : , : Ibero-American Journals (IBJ) | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Intellectual property rights in pharmaceutical test data : origins, globalisation, and impact / / Adam Buick |
Autore | Buick Adam <1944-> |
Edizione | [First edition.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2023] |
Descrizione fisica | 1 online resource (xvi, 227 pages) |
Disciplina | 346.048 |
Soggetto topico |
Clinical pharmacology
Drug development Drugs - Testing - Law and legislation Industrial property (International law) |
ISBN |
9783031294365
9783031294358 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Acknowledgements -- Contents -- Abbreviations -- List of Figures -- List of Tables -- Chapter 1: Introduction -- 1.1 Introduction -- 1.2 Regulation and Globalisation -- 1.3 Scope and Aims of This Book -- 1.4 Methodology -- 1.5 Structure of This Book -- References -- Chapter 2: An Overview of the Protection of Submitted Test Data -- 2.1 Introduction -- 2.2 Pharmaceutical Test Data and the Drug Development Process -- 2.3 Test Data Exclusivity -- 2.3.1 Test Data Exclusivity and Other Intellectual Property Rights -- 2.3.1.1 The Relationship Between Test Data Exclusivity and the Patent System -- 2.3.1.2 The Relationship Between Test Data Exclusivity and Trade Secrets -- 2.3.1.3 The Relationship Between Test Data Exclusivity and Other Forms of Non-Patent Exclusivity -- 2.3.2 Test Data Exclusivity at the International Level -- 2.4 The Test Data Exclusivity Debate -- 2.4.1 Conflicts Between Test Data Exclusivity and the Logic of Patent Law -- 2.4.1.1 Incentivising Delayed Drug Launches -- 2.4.1.2 Undermining Measures Designed to Promote Public Health -- 2.4.1.3 Lack of Disclosure of Information -- 2.4.1.4 Absence of Appeal Mechanisms -- 2.5 Test Data Exclusivity and Biologic Drugs -- 2.5.1 The Origins and Development of Abbreviated Approval Pathways for Biosimilars -- 2.5.2 Approaches to Test Data Exclusivity for Data Submitted in Association with Biologics -- 2.6 Alternatives to Test Data Exclusivity -- 2.7 The Impact of Test Data Exclusivity on Access to Medicine -- 2.8 Conclusion -- References -- Chapter 3: The Origins of Test Data Exclusivity -- 3.1 Introduction -- 3.2 The History of Pharmaceutical Regulation in the US and the Origins of Test Data Exclusivity -- 3.2.1 Elixir Sulfanilamide, Thalidomide and Pre-marketing Approval -- 3.2.2 The Crisis of the Late 1970s and the Drug Price Competition and Patent Term Restoration Act.
3.3 The Origins of Test Data Exclusivity in Europe and Japan -- 3.4 Conclusion -- References -- Chapter 4: The Protection of Submitted Test Data and the TRIPS Agreement -- 4.1 Introduction -- 4.2 Article 39.3 -- 4.3 The History of the Protection of Submitted Test Data in TRIPS -- 4.3.1 Intellectual Property and the Uruguay Round -- 4.3.1.1 Parallel Negotiations -- 4.3.2 The Protection of Undisclosed Data -- 4.3.3 The Proposals on the Protection of Submitted Test Data -- 4.4 Interpreting Article 39.3 -- 4.4.1 Unfair Commercial Use -- 4.4.2 Other Terms -- 4.4.2.1 New Chemical Entity -- 4.4.2.2 The Submission of Undisclosed Test or Other Data -- 4.4.2.3 Considerable Effort -- 4.4.2.4 Prohibition on Disclosure -- 4.4.3 What Must Members Do to Comply with Article 39.3? -- 4.4.3.1 Does Article 39.3 Prohibit the Use of Submitted Test Data in Relation to Compulsory Licensing or Other Measures Design... -- 4.5 The Significance of Article 39.3 -- 4.6 Conclusion -- References -- Chapter 5: The Globalisation of Test Data Exclusivity -- 5.1 Introduction -- 5.2 The Protection of Submitted Test Data and Trade Post-TRIPS -- 5.3 Test Data Exclusivity in Trade Agreements -- 5.3.1 Discussion of US-Led Trade Agreements -- 5.3.1.1 Term and Scope of Protection -- 5.3.1.2 Biologics -- 5.3.1.3 Article 39.3 Criteria -- 5.3.1.4 Additional Requirements -- 5.3.1.5 Exceptions -- 5.3.1.6 Concluding Remarks on Test Data Exclusivity Provisions in US-Led Trade Agreements -- 5.3.2 Discussion of EFTA and Swiss-Led Agreements -- 5.3.2.1 Alternatives to Test Data Exclusivity -- 5.3.2.2 Term and Scope of Protection -- 5.3.2.3 Biologics -- 5.3.2.4 Article 39.3 Criteria -- 5.3.2.5 Additional Requirements -- 5.3.2.6 Exceptions -- 5.3.2.7 Concluding Remarks on Test Data Exclusivity Provisions in EFTA/Swiss-Led Agreements -- 5.3.3 Discussion of EU-Led Agreements. 5.3.3.1 Term and Scope of Protection -- 5.3.3.2 Biologics -- 5.3.3.3 Article 39.3 Criteria -- 5.3.3.4 Additional Requirements -- 5.3.3.5 Exceptions -- 5.3.3.6 Concluding Remarks on Test Data Exclusivity Provisions in EU-Led Agreements -- 5.3.4 Concluding Remarks on Test Data Exclusivity and Trade Agreements -- 5.4 Test Data Exclusivity and Accession to the World Trade Organisation -- 5.5 The Globalisation of Test Data Exclusivity and the Role of Coercion -- 5.6 Explaining the Globalisation of Test Data Exclusivity -- 5.7 Conclusion -- References -- Untitled -- Chapter 6: Approaches to the Implementation of the Protection of Submitted Test Data -- 6.1 Introduction -- 6.2 Non-exclusivity Based Approaches to the Protection of Submitted Test Data -- 6.2.1 Jurisdictions with No Regulatory Framework for the Protection of Submitted Test Data -- 6.2.2 Jurisdictions Which Protect Submitted Test Data Only Against Misappropriation -- 6.2.3 Jurisdictions with Ambiguous Provisions on the Protection of Submitted Test Data -- 6.2.4 Does It Matter if These Approaches Do Not Conform with Article 39.3? -- 6.3 Test Data Exclusivity at the National Level -- 6.4 National Approaches to Test Data Exclusivity -- 6.4.1 Methodology -- 6.4.2 General Observations -- 6.4.3 Basic Test Data Exclusivity Protection -- 6.4.3.1 Term -- 6.4.3.2 Data Exclusivity Per Se and Market Exclusivity -- 6.4.3.3 Qualification for Protection -- 6.4.4 Protection for Other Types of Submitted Test Data -- 6.4.4.1 Protection for Data Submitted Regarding Non-novel Uses of Small Molecule Drugs -- 6.4.4.2 Protection for Data Submitted Regarding Biologic Drugs -- 6.4.5 Disclosure of Submitted Test Data -- 6.4.6 Exceptions to Test Data Exclusivity -- 6.5 Conclusion -- References -- Chapter 7: The Impact of Test Data Exclusivity on Abbreviated New Drug Applications in the United States -- 7.1 Introduction. 7.2 The Potential Impact of Test Data Exclusivity -- 7.3 The Impact of Test Data Exclusivity in the United States 1999-2009 -- 7.3.1 The US Drug Approval System in Detail -- 7.3.1.1 Patent Law -- 7.3.1.2 Market Authorisation -- 7.3.1.3 Test Data Exclusivity -- 7.3.1.4 Other Forms of Exclusivity -- 7.3.2 Method -- 7.3.3 Findings -- 7.3.4 Discussion -- 7.4 Conclusion -- References -- Chapter 8: The Impact of Test Data Exclusivity on Measures for the Protection of Public Health -- 8.1 Introduction -- 8.2 Test Data Exclusivity and Measures for the Protection of Public Health -- 8.2.1 Compulsory Licensing of Pharmaceuticals and Test Data Exclusivity Post-TRIPS -- 8.2.2 Test Data Exclusivity and the Response to COVID-19 -- 8.2.2.1 Test Data Exclusivity and the Proposed TRIPS Waiver -- 8.2.2.2 Compulsory Licensing During the COVID-19 Pandemic -- 8.2.3 The Impact of Test Data Exclusivity on Measures for the Protection of Public Health -- 8.3 Reconciling Test Data Exclusivity and Measures for the Protection of Public Health -- 8.4 Conclusion -- References -- Chapter 9: Conclusion -- 9.1 Findings of This Book -- 9.2 Implications for the Future -- 9.3 Concluding Remarks -- References -- Appendix A: The Following Tables A1, A2 and A3 Contain the Data Used at Sect. 6.4.3.1 for the Purposes of Calculating the Impa... -- Appendix B: The Following Table A4 Contains the Data Used in Chap. 7 for the Purposes of Calculating the Impact of Test Data E. |
Record Nr. | UNINA-9910725085903321 |
Buick Adam <1944->
![]() |
||
Cham, Switzerland : , : Springer, , [2023] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Journal of anaesthesiology clinical pharmacology |
Pubbl/distr/stampa | New Delhi, India, : Research Society of Anaesthesiology Clinical Pharmacology |
Soggetto topico |
Anesthesiology
Clinical pharmacology Anesthesia Pharmacology, Clinical |
Soggetto genere / forma |
Periodical
Periodicals. |
ISSN | 2231-2730 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Journal of anesthesiology clinical pharmacology |
Record Nr. | UNISA-996215302003316 |
New Delhi, India, : Research Society of Anaesthesiology Clinical Pharmacology | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Journal of anaesthesiology clinical pharmacology |
Pubbl/distr/stampa | New Delhi, India, : Research Society of Anaesthesiology Clinical Pharmacology |
Soggetto topico |
Anesthesiology
Clinical pharmacology Anesthesia Pharmacology, Clinical |
Soggetto genere / forma |
Periodical
Periodicals. |
ISSN | 2231-2730 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Journal of anesthesiology clinical pharmacology |
Record Nr. | UNINA-9910136099603321 |
New Delhi, India, : Research Society of Anaesthesiology Clinical Pharmacology | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Journal of clinical pharmacy and therapeutics |
Pubbl/distr/stampa | [Oxford, England], : Blackwell Science |
Disciplina | 615 |
Soggetto topico |
Clinical pharmacology
Chemotherapy Pharmacy Therapeutics Drug Therapy Pharmacology Drugs and pharmacology Health Klinische Pharmazie Zeitschrift Online-Ressource Chimiothérapie Pharmacologie clinique |
Soggetto genere / forma |
Periodicals.
Ressource Internet (Descripteur de forme) Périodique électronique (Descripteur de forme) |
Soggetto non controllato | Health |
ISSN | 1365-2710 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Journal of clinical pharmacy & therapeutics |
Record Nr. | UNINA-9910147342103321 |
[Oxford, England], : Blackwell Science | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|